Else Nutrition Holdings Inc (BABY) News

LOLOLOL. Hardly. Borrows are often fully backed with cheap Reg S conv stock that can be dumped into the market quickly. You may be a dumb penny player, but the lenders aren't.

"Apparently there is a lender convinced they will survive."

Apparently there is a lender convinced they will survive.

Till the incompetent stupid woman gives up (do not hold your breath) this will remain a desastrous investment. The woman is stubborn up to ending up bancrupt before she accept that she is destroying her toy. To bad ... She had an opportunity and did destroy it by being stupid.

No wonder it keeps dropping.
"Else Nutrition expects to use the proceeds for general working capital." in other words, pay raises perhaps.


Else Nutrition Amends Convertible Security Financing
7:35 AM ET 1/24/25 | MT Newswires
Else Nutrition Amends Convertible Security Financing
07:35 AM EST, 01/24/2025 (MT Newswires) -- Else Nutrition (BABY.TO), trading near its 52-week low, overnight Thursday said it signed a non-binding term sheet with Lind Global Fund II, pursuant to which both parties expect to amended a convertible security funding agreement for US$1.2 million in proceeds.

The company and Lind expect the proposed new funding to be completed in four tranches with the initial US$300,000 to be funded by Lind upon closing, followed by three additional tranches on April 1, July 1, and Oct. 1. Else Nutrition will issue convertible securities to Lind with a face value of US$375,000 for each tranche, with each convertible security having a 24-month maturity date.

Each convertible security is convertible into common shares after the 120-day lock-up period. The company will also issue detached warrants to Lind to buy shares related to the new funding and will be exercisable for 48 months from the date of issuance with an exercise price equal to 100% of the 5-day VWAP immediately prior to the closing date.

Else Nutrition expects to use the proceeds for general working capital.

Shares of the company closed up $0.0050 or 16%, to $0.0350 on Thursday on the Toronto Stock Exchange.

Please read all the important disclosures below.
Investing:
Check the background of Morgan Stanley Smith Barney LLC on FINRA's BrokerCheck and see the Morgan Stanley Smith Barney LLC Relationship Summary.

Else Nutrition Amends Convertible Security Financing
7:35 AM ET 1/24/25 | MT Newswires
Else Nutrition Amends Convertible Security Financing
07:35 AM EST, 01/24/2025 (MT Newswires) -- Else Nutrition (BABY.TO), trading near its 52-week low, overnight Thursday said it signed a non-binding term sheet with Lind Global Fund II, pursuant to which both parties expect to amended a convertible security funding agreement for US$1.2 million in proceeds.

The company and Lind expect the proposed new funding to be completed in four tranches with the initial US$300,000 to be funded by Lind upon closing, followed by three additional tranches on April 1, July 1, and Oct. 1. Else Nutrition will issue convertible securities to Lind with a face value of US$375,000 for each tranche, with each convertible security having a 24-month maturity date.

Each convertible security is convertible into common shares after the 120-day lock-up period. The company will also issue detached warrants to Lind to buy shares related to the new funding and will be exercisable for 48 months from the date of issuance with an exercise price equal to 100% of the 5-day VWAP immediately prior to the closing date.

Else Nutrition expects to use the proceeds for general working capital.

Shares of the company closed up $0.0050 or 16%, to $0.0350 on Thursday on the Toronto Stock Exchange.

Please read all the important disclosures below.
Investing:
Check the background of Morgan Stanley Smith Barney LLC on FINRA's BrokerCheck and see the Morgan Stanley Smith Barney LLC Relationship Summary.

All our CEO cares about is ''PRODUCTS'' charasteristics. I do not care how many products she now has or will develop, till she or someone can MARKETING THEM, our shares will remain worthless.
Unfortunately, our CEO is alergic at marketing, considers that to be a useless expense and will keep issuing PR's aimed at shareholders.
What a mess that incompetent CEO has been and is making out of a great opportunity.

Else Nutrition Expands into Adult Nutrition Market with Launch of its Innovative Plant-based Ready-to-Drink Shakes
7:00 AM ET 1/21/25 | Dow Jones

Else Nutrition Expands into Adult Nutrition Market with Launch of its Innovative Plant-based Ready-to-Drink Shakes

Canada NewsWire

VANCOUVER, BC, Jan. 21, 2025

The U.S. dairy alternatives market is forecasted to grow from $5.84 billion in 2022 to $14.28 billion by 2030, reflecting a significant consumer shift toward plant-based products

VANCOUVER, BC, Jan. 21, 2025 /CNW/ - ELSE NUTRITION HOLDINGS INC. (BABY) (BABYF) (0YL.F) ("Else" or the "Company"), a leader in clean, Plant-Based nutrition, announces its entry into the adult food market with the launch of its revolutionary ready-to-drink (RTD) nutritional shakes for adults in the U.S. and Canada.

As the first and only whole-food, plant-powered, complete nutrition drink for adults, Else Nutrition's RTD shakes are poised to redefine the adult nutritional beverage market. Notably, the U.S. dairy alternatives market is forecasted to grow from $5.84 billion in 2022 to $14.28 billion by 2030, reflecting a significant consumer shift toward plant-based products. Furthermore, 44% of flexitarians cite health benefits as a key driver in choosing plant-based options. Else Nutrition's RTD shakes meet this growing demand, offering a superior product that aligns with vegan, vegetarian, and flexitarian dietary preferences.

As more consumers embrace plant-based diets and seek sustainable, clean-label products, Else Nutrition's Adult RTD shakes offer a timely and innovative solution. Made from real, whole-food ingredients like almond butter, sunflower protein flour, and buckwheat flour, these dairy-free, minimally processed shakes provide a nutritious, easy-to-digest alternative to traditional dairy-based nutritional supplements.

A Complete Nutritional Solution

Each serving of Else Nutrition's RTD shake provides:
-- 280 calories and 14g of high-quality plant protein

-- Natural fiber, healthy carbohydrates, and unsaturated fats

-- 26 essential vitamins and minerals tailored to adults' health needs

-- 50% less sugar than leading competitors with no artificial sweeteners

-- Lactose-free, cholesterol-free, low in saturated fat, and Clean Label
Project Certified

Else Nutrition's RTD Vanilla shakes are now available in Canada in 8 fl. oz. (236 mL) tetra packs, offered in 6-packs and 24-packs. They can be purchased on Amazon.ca and at select retail locations. Additional flavors are planned for future release. In the U.S., the product line is set to launch in Q2 2025.

"We are proud to introduce a convenient, clean, and delicious option for adults looking to meet their daily nutritional needs," said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. "This launch is a natural progression of our mission to deliver whole-food-based nutrition for all ages. Our adult shakes aren't just better for you and easier to digest--they're better for the planet."

To delve deeper into Else Nutrition's offerings and its revolutionary approach to nutrition, visit www.elsenutrition.com

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and whole Plant-Based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, Plant-Based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit

-- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler
Formula Category

-- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo

-- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category

Thia (and another little one) are toys to play with using money I ca afford to lose. However to be honest, initially (bought at $0,38) I tought Baby was an opportunity and for a while I did enjoy trading it so I got more shares and kept a very low net cost. I however did not know the CEO was annything but a serious tecky with no competence whatsoever in managing a good company. Over and above being incompetent in business managing she also demonstrated she was stupidly stubborn, refusing to see what was happening. I therefore lose my initial investment that became a ''BET'' and am sorry to conclude that I found out to late that our CEO was outright incompetent. In penny stock, you lose some, you win some ... Baby revealed to be an opportunity destroyed by incompetence.

Is it going to fall ANOTHER 24%? With troubled, low quality stocks the best time to sell is NOW. Or best, never buy in the first place which is my method (I only buy large cap exchange-listed blue chips or high quality funds. And I always study and understand the audits.

That would be the death kiss.

tax selling next week will probably see 5-10 million share days.

R/S?????

I agree but with her ???

I don't think she will bankrupt the company but find a buyer

Innovative??? "Gee, a mix of almonds, buckwheat, and tapioca."

When I bought my first shares at $0,38 (2019-12-11), the product involved was extremely attractive and inovative). Initially, people rightfully did believe in the product created by someone understanding the scientific value of what she developped (PPS up to $4,26 on 2020-12-09).

Thereafter for more or less 9 months, the stock gave a great opportunity for trading (PPS swingning up down between $ 2.0 and $ 4.00 before it went downhill for good because,for whatever reason our CEO tought she knew better than anyone. In fact she had a personal hatrerd for whatever is called ''Marketing'' a useless EXPENSE in her mind. That created her failure.

Her stupidity made her refuse to see the obvious: ''Products however great they are cannot sell if market is not made aware of what they are and offer'' (Lesson well learn by Japaneeses and their Beta technology, against en inferior american VHS technology).

What a shame

The stock wasn't a penny stock back then. Now going to sub-penny.

You would have tripled your money in an S&P 500 Index fund during that period. Can't think of many things dumber than an IHUB-shilled penny stock.

I can wait. Have been invested for 4+ years

Just wait a little. The CEO will do it for you with or without dumb sellers. Never saw that an incompetent business person. She started with a golden opportunity and made a disaster of it by refusing to read the writings on the wall since the beguinning. Looking for a dumb person ... She is.

looking for dumb sellers so I can buy at .0001

LOL

Does BABYF drop 24% Every week?

beginning of another "great week"

End of another great week

Dumbest investors I've ever seen. Now off 24% today alone. Insiders clearly dumping.

Right but she would thereby admit defeat and I think she would not be able to do so.
Alternatively, finding a solid mass marketing professional and supporting him blindly (financing, planning, executing) could still save the company. I however again believe her ego would not accept that also.

seems as though the only salvation is finding a buyer

Soon to be a sub penny stock if our CEO keeps looking at it with her incredible incompetence (I almost have no doubt she will do so). I've been around stock markets for decades but never saw any executive that incompetent and stubborn. When I bought it initially (2019-12-13 BUY 1800 0,380 684,00 $ 9,95 $ 693,95) $) I really tought I had found a golden opportunity. Fortunately I thereafer traded somewhat accumulating shares an saving cash but it is absolutely incredible to withness that level of stupididy blowing up such an opportunity. Ho ... You win some, you lose some.

Agree 100%.

pual, "The woman is a disaster."
CORRECT, pps tells the story in no uncertain terms.

The woman is a disaster. She doesn't have a clue relative to what managing a MASS MARKETING OPERATION represents. She is a lab-rat, only concern by product. She operates in a mass marketing business but think marketing (an investment) is an expense to cut. More incompetent than that, you lead yourself to bancrupcy.
A few abstract from her NR:
- managing expenses.
- despite a very modest marketing budget.
- additional major US retailer.
- our products would be available in over 900 new US large grocery stores
- ongoing product innovations
- upcoming launch of our Adult RTD product,
- broaden our offerings
"To support our growth, we are in active discussions regarding non-dilutive bridge funding, and a long-term credit line’’.
Weren't my shares wortthless I would sell them.
‘’Concurrently, we've implemented strategic cost-saving measures aimed at improving our margins in future quarters.’’

Else Nutrition Reports 2024 Third Quarter Financial Results and Provides Business Update
7:45 AM ET 11/14/24 | Dow Jones

Else Nutrition Reports 2024 Third Quarter Financial Results and Provides Business Update

Canada NewsWire

VANCOUVER, BC, Nov. 14, 2024

Conference call to be held today at 10:00 AM Eastern Time

VANCOUVER, BC, Nov. 14, 2024 /CNW/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), today reported financial results for the third quarter ended September 30, 2024. The financial statements and MD&A are available on SEDAR under the Company's profile.

Hamutal Yitzhak, CEO of Else Nutrition, commented, "We are making steady progress executing our growth strategy, while carefully managing expenses. We achieved a 5% year-over-year revenue increase in Q3 2024, despite a very modest marketing budget. Our ability to achieve these results demonstrates the growing consumer appetite for our products and our expanding retail presence."

"We are continuing to gain traction with retailers across North America, including our recent pilot program with Costco -- one of the largest North American wholesale retailers. We believe this could lead to distribution across more than 100 of their locations in Canada as a first step with the potential to expand throughout the US. This expansion represents a substantial opportunity to reach new consumers and build our brand. We are also in the process of finalizing the expanded availability of our kids RTD products with an additional major US retailer. Once finalized, our products would be available in over 900 new US large grocery stores, further enhancing our market reach. Additionally, we are proud of our ongoing product innovations, including the upcoming launch of our Adult RTD product, with the first commercial production scheduled for later this year. This is a key milestone as we broaden our offerings to meet the demand for convenient, healthy whole food, minimally processed and easy to digest, plant-based nutrition."

"To support our growth, we are in active discussions regarding non-dilutive bridge funding, and a long-term credit line that will enable us to ramp up our marketing efforts, optimize our capital structure, and drive our long-term growth strategy. Concurrently, we've implemented strategic cost-saving measures aimed at improving our margins in future quarters. We believe these operational improvements, combined with innovative product launches and an expanding retail presence, are positioning us for long-term financial success."

"Looking forward, we believe as we continue to execute on our financial strategy, it will enable us o expand our retail footprint, increase brand visibility, and continue to develop high-demand plant-based products. Our commitment to providing healthy, sustainable nutrition options places us at the forefront of the plant-based nutrition market, and we are excited about the opportunities that lie ahead."

2024 Third Quarter Financial Results

All figures are in CAD unless otherwise indicated.
-- Revenue for Q3 2024 increased approximately 5% to $1.8 million compared
to $1.71 million for the same period last year.

-- Operating expenses for Q3 2024 was $3.6 million compared to $3.5 million
in Q3 2023.

-- Cash balance as of September 30, 2024, was $0.9 million (including
restricted cash).

Conference Call

Else Nutrition management plans to host a business update conference call at 10:00 a.m. Eastern Time on November 14, 2024, to discuss the Company's financial results for the 2024 third quarter ended September 30, 2024, as well as the Company's corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 1-877-704-4453 for U.S. callers or +1-201-389-0920 for international callers. A webcast of the call may be accessed at https://viavid.webcasts.com/starthere.jsp?ei=1696583&tp_key=1ad8612838 or on the Investor Relations section of the Company's website at https://investors.elsenutrition.com/.

A webcast replay will be available on the Investor Relations section of the Company's website (https://investors.elsenutrition.com/), through November 14, 2025. A telephone replay of the call will be available approximately three hours following the call, through November 21, 2024, and can be accessed by dialing 1-844-512-2921 for U.S. callers or +1-412-317-6671 for international callers and entering conference ID: 13750029.

To delve deeper into Else Nutrition's offerings and its revolutionary approach to kids' nutrition, visit www.elsenutrition.com

About Else Nutrition Holdings Inc.

Else Nutrition Holdings Inc. (TSX: BABY, OTCQX: BABYF, FSE: 0YL) is a food and nutrition company in the international expansion stage focused on developing innovative, clean, and plant-based food and nutrition products for infants, toddlers, children, and adults. Its revolutionary, plant-based, non-soy formula is a clean-ingredient alternative to dairy-based formulas. Since launching its Plant-Based Complete Nutrition for Toddlers, made of whole foods, almonds, buckwheat, and tapioca, the brand has received thousands of powerful testimonials and reviews from parents, gained national retailer support, and achieved rapid sales growth.

Awards and Recognition:
-- "2017 Best Health and Diet Solutions" award at Milan's Global Food
Innovation Summit

-- #1 Best Seller on Amazon in the Fall of 2020 in the New Baby & Toddler
Formula Category

-- "Best Dairy Alternative" Award 2021 at World Plant-Based Expo

-- Nexty Award Finalist at Expo West 2022 in the Plant-Based lifestyle
category

-- During September 2022, Else Super Cereal reached the #1 Best Seller in
Baby Cereal across all brands on Amazon

-- In May 2024 Else Nutrition's Ready-to-Drink Kids Vanilla Shake Named
Among the Best in Family-Friendly Products by the Prestigious Mom's
Choice Awards(R)

TSX

Neither the TSX nor its regulation services provider (as that term is defined in the policies of the TSX) accept responsibility for the adequacy or accuracy of this release.

You can buy all the worthless patents and trademarks you want virtually free on eBay. Try it using the link below! Start your own junk penny stock.

Of course the better ones are almost expired...with only a few days left in them. Maybe an idiot or two might fall for it.

https://www.ebay.com/b/Patents-Trademarks-for-Sale/

pual, I wouldn't be surprised if the patents are owned by individual's, NOT the company.

VANCOUVER, BC, Nov. 6, 2024 /PRNewswire/ - ELSE NUTRITION HOLDINGS INC. (TSX: BABY) (OTCQX: BABYF) (FSE: 0YL.F) ("Else" or the "Company"), today announced that it plans to host a business update conference call at 10:00 a.m. Eastern Time on November 14, 2024 to discuss the Company's financial results for the 2024 third quarter ended September 30, 2024, as well as the Company's corporate progress and other developments.

If she has any smarts left, she tries to sell out the outfit but with current market value the pressure to give it for negligeable amount up would be great. However, I suspect the market value reflect the incompetence of our CEO but, taking her out of the picture gives our product line, patents and rights, a much greater value, In any case is our CEO dumb enough to not understand her stuborness is going to sink the boat sooner than later?

usually there is a PR indicating the next quarter report. All quiet from HQ.
PPS acting like belly up.

I wonder if our dreaming CEO finally figured out she has to sell out before she and we have to write off our investment?

I wonder if our dreaming CEO finally figured out she has to sell out before she and we have to write off our investment?

Someone is buying heavy. Look at the capitulation

A buyer steps up to bat @ .03.
$0.030.00 (0.00%)
Bid x Size
$0.03 x 2,024,987
Ask x Size
$0.0403 x 10,000
Real Time Equity Quote: Oct 14, 2024, 9:30 AM ET

there is no submission - FDA does not approve infant formula - they just set basic requirements

Anyone knows where we stand relative to our submission(s) to the FDA?

This is either a RS or trips before year end

Could be but I think she finances herself by increasing the number of O\S

How about a current honest value on The liabilities? The Debt? $Thousands? $Millions ???????? More?

Without an audit, I'd assume the numbers are really ugly

Our incompetent CEO is in panic and to stupid to look for help from a business type person. She enjoys a board made of scientifics discussing scientific subjects. for more than 3 years she did nothing to try to understand why the value of her company went down the drain. What a crazy dreamer !!!

Why no recent audits??? How hard would it be to put a current honest value on almonds, buckwheat and tapioca?

"When was the last time BABYF released audited numbers?"

Another way to do it. Good luck.